nitrazepam "dak" 5 mg tabletter
orifarm healthcare a/s - nitrazepam - tabletter - 5 mg
nitrazepam "accord" 5 mg tabletter
accord healthcare b.v. - nitrazepam - tabletter - 5 mg
lorazepam "orifarm" 1 mg tabletter
orifarm generics a/s - lorazepam - tabletter - 1 mg
lorazepam "orion" 1 mg tabletter
orion corporation - lorazepam - tabletter - 1 mg
lorazepam "macure" 4 mg/ml injektionsvæske, opløsning
macure pharma aps - lorazepam - injektionsvæske, opløsning - 4 mg/ml
lorazepam "2care4" 1 mg tabletter
2care4 aps - lorazepam - tabletter - 1 mg
pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)
astrazeneca ab - reassortant influenzavirus (levende svækket) af følgende stamme: a / vietnam / 1203/2004 (h5n1) stamme - influenza, human - vacciner - profylakse af influenza i en officielt erklæret pandemisk situation hos børn og unge fra 12 måneder til under 18 år. pandemic influenza vaccine h5n1 astrazeneca bør anvendes i overensstemmelse med officielle retningslinjer.
tremelimumab astrazeneca
astrazeneca ab - tremelimumab - carcinom, ikke-småcellet lunge - antineoplastiske midler - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacciner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.
trazec
novartis europharm ltd. - nateglinid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - nateglinid er indiceret til kombinationsbehandling med metformin hos type 2 diabetespatienter utilstrækkeligt kontrolleret trods en maksimalt tolereret dosis af metformin alene.